Open Orphan

42 results

From left: Prof Luke O’Neill, independent non-executive director and scientific advisor at Poolbeg Pharma; Ian O’Connell, chief financial officer; Jeremy Skillington, chief executive at Poolbeg Pharma; Cathal Friel, non-executive chairman. Photograph: Jason Clarke

Dublin-listed pharmaceutical services company Open Orphan will seek admission of its spin-out company Poolbeg Pharma to trade on the London Stock Exch(...)

Open Oprhan executive chairman Cathal Friel: “We remain on target with all of our plans as we continue to build the company going forward.”

Dublin-listed pharma services company Open Orphan has received court approval for a reduction in capital as part of a process to spin out some of its (...)

Open Orphan executive chairman Cathal Friel.

Dublin-listed pharmaceutical services company Open Orphan has announced that its subsidiary hVivo has signed a £3 million contract to develop a “chall(...)

Cathal Friel: “We now have an opportunity to deliver significant further shareholder value by the demerger of these non-core assets”

Dublin-listed pharmaceutical services company Open Orphan said it is planning for a possible spin-out of some of its non-core development intellectual(...)

Cathal Friel, executive chairman   of Open Orphan, a European-focused, rare and orphan drug consulting services platform

Dublin-listed pharmaceutical services company Open Orphan’s subsidiary Hvivo has won a contract worth €7.5 million to run a human viral challenge stud(...)

Open Orphan has secured ethical approval for a trial that involves deliberately infecting people with the Covid virus.

Open Orphan, the Irish clinical trials group, has secured ethical approval for a trial that involves deliberately infecting people with Covid in a con(...)

Open Orphan executive chairman Cathal Friel

Drug development company PrEP Biopharm said it has successfully completed a toxicology study for a potential prophylactic nasal spray that could be us(...)

Open Orphan executive chairman Cathal Friel.

Dublin-listed pharmaceutical services company Open Orphan has announced a contract renewal extending its consultancy services with a major global phar(...)

Cathal Friel, executive chairman of Open Orphan

Dublin-listed pharmaceutical services company Open Orphan has received approval from the UK drugs regulator to conduct its nasal Covid-19 vaccine clin(...)

Venn Life Sciences is to help manage a Covid-19 drug study.

Venn Life Sciences, a subsidiary of Irish based Open Orphan, has been awarded two new contracts, including a Covid-19 drug trial. Open Orphan is a s(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • Last »